VTYX Ventyx Biosciences, Inc.
Healthcare$14.00+0.00%ClosedMarket Cap: $1.00B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.22
P/S
0.00
EV/EBITDA
-8.65
DCF Value
$0.21
FCF Yield
-8.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-48.1%
ROA
-50.4%
ROIC
-58.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | NaN% | $-24.9M | $-22.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-29.3M | $-27.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-30.1M | $-27.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-32.4M | $-29.4M | $— | — |
| FY null | $0.00 | NaN% | $-148.4M | $-135.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-38.6M | $-35.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-35.7M | $-31.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-41.8M | $-38.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-50.3M | $-46.8M | $— | — |
| FY null | $0.00 | NaN% | $-208.0M | $-193.0M | $— | — |
| Q3 2023 | $0.00 | NaN% | $-58.0M | $-54.0M | $-0.92 | — |
| Q2 2023 | $0.00 | NaN% | $-57.1M | $-53.3M | $-0.91 | — |